Analytical Data
-
Gene name
CABIN1
- Application
-
Alternative Names
CABIN1；KIAA0330；Calcineurin-binding Protein cabin-1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y6J0
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CABIN1 (Calmodulin-Binding Protein 1) is a multifunctional protein that plays a crucial role in various cellular processes, including immune responses and transcription regulation. Emerging research has highlighted its importance in T cell signaling and differentiation, as CABIN1 interacts with key signaling molecules such as calmodulin and nuclear receptor co-repressors. Its involvement in immune modulation makes it a significant factor in autoimmune diseases and cancer, where dysregulation of immune responses is often observed. Recent studies have focused on the structural and functional characterization of CABIN1 to better understand its mechanisms of action. These investigations aim to explore how CABIN1 regulates gene expression and its potential as a therapeutic target. Furthermore, by elucidating the pathways through which CABIN1 operates, researchers hope to uncover novel approaches for enhancing immune responses or mitigating autoimmunity. The growing body of literature suggests that CABIN1 may also serve as a biomarker for certain diseases, mediated by its expression levels in immune cells. Thus, the study of CABIN1 is not only pivotal in understanding basic immunological principles but also holds promise for developing innovative treatments for immune-related disorders. Overall, CABIN1 stands out as a protein of significant interest in both basic and translational research, with potential implications for improving human health through targeted therapies.
